Joyce Pagan

Editor https://www.cancertherapyadvisor.com

Joyce Pagan is the editor of Oncology Nurse Advisor, part of the Haymarket Oncology brands. Prior to taking the helm of Oncology Nurse Advisor, Joyce held many roles in medical publishing brands ranging from design, production, and editorial that served various specialties.

All articles by Joyce Pagan

Anticoagulant efficacy to prevent VTE after hip and knee arthroplasty

JADPRO 2022

Risk of VTE 6-Fold Higher in CLL/MBL Than in General Population

Joyce Pagan

October 25, 2022

Patients with chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis have an increased risk of venous thromboembolism, a study suggests.

Discussing a treatment regimen with a patient.

JADPRO 2022

More Resources Needed for African-American Women Who Survive Breast Cancer

Joyce Pagan

October 25, 2022

African-American women who survive breast cancer do not get adequate resources to support their mental and emotional health, a small study suggests.

JADPRO 2022

Cost and Coordination of Care Head List of Concerns With Combination IV/Oral Therapy

Joyce Pagan

October 24, 2022

Results of an ACCC study revealed advanced practitioners’ greatest challenges when treating cancer patients with combination IV/oral therapies.

Conceptual image of intermittent fasting.

JADPRO 2022

Still Unclear Whether Intermittent Fasting Can Improve Cancer Outcomes

Joyce Pagan

October 24, 2022

Intermittent fasting appears safe as an adjunct to chemotherapy, but it is unclear whether this diet can improve cancer outcomes.

ONS Congress 2022

Task Force Improves Mediport Infection Rates in Ambulatory Patients With Cancer

Joyce Pagan

May 10, 2022

A plan for reducing mediport infections in ambulatory patients was described at the 2022 ONS Congress.

The development of BRCA-targeted therapies might offer the best opportunities to bring pancreatic ca

ONS Congress 2022

Engaging Patients to Improve Genetic Risk Assessment and Testing

Joyce Pagan

May 6, 2022

Preliminary results of a study comparing outreach methods for engaging patients in genetic risk assessment and testing are presented.

ONS Congress 2022

Benefits of Survivorship Clinic Outweigh Potential Costs

Joyce Pagan

May 6, 2022

Survivorship clinics offer benefits for patients, health care providers, and health care organizations, research suggests.

ONS Congress 2022

Health-Promoting Behaviors: A Measure of Caregiver Burden in the Cancer Setting

Joyce Pagan

May 5, 2022

Researchers sought to classify health-promoting behavior levels among family caregivers of patients with cancer and to identify risk factors for low levels.

ONS Congress 2022

Addressing Fertility Risks and Preservation in Adolescent and Young Adult Patients With Cancer

Joyce Pagan

May 4, 2022

A team of oncology clinicians sought to identify barriers to fertility discussions with AYA patients and implement strategic changes to eliminate those barriers.

ONS Congress 2022

Potential of Cannabis, Cannabinoid Products in Managing Cancer Symptom Burden

Joyce Pagan

May 3, 2022

Researchers conducted a literature search for evidence of the effects of medical marijuana products on symptom burden in patients with cancer.

Next post in ONS Congress 2022